Skip to main navigation Skip to search Skip to main content

Engineered Circular RNA CircmiR-29b Attenuates Muscle Atrophy by Sponging MiR-29b

  • Jin Li
  • , Rui Chen
  • , Yongjun Zheng
  • , Weilin Yuan
  • , Tingting Yang
  • , Xiaolan Zhu
  • , Yuwei Yan
  • , Bing Jin
  • , Wanru Xu
  • , Zhongrong Zhang
  • , Guoping Li
  • , Priyanka Gokulnath
  • , Zhiyong Lei
  • , Junjie Xiao*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Muscle atrophy is commonly caused by various diseases but still lacks effective treatment in clinical practice. Here, an artificial circular RNA (circRNA) named circmiR-29b, which is designed to be a molecular sponge for miR-29b containing 12 imperfect bulged miR-29b binding sites is constructed. CircmiR-29b shows a favorable functional effect with respect to miR-29b repression in a specific and drastic manner. CircmiR-29b can protect against in vitro muscle atrophy induced by dexamethasone (Dex), angiotensin II (Ang II), and tumor necrosis factor alpha (TNF-α). Besides, circmiR-29b attenuates in vivo muscle atrophy induced by denervation, immobilization, and Ang II. More importantly, skeletal muscle specific gene therapy using circmiR-29b is able to attenuate established muscle atrophy induced by spiral wire immobilization. This work has developed an engineered circmiR-29b acting as an miR-29b sponge, and offers a promising therapeutic tool to prevent muscle atrophy.

Original languageEnglish
Article number2200029
JournalAdvanced Therapeutics
Volume5
Issue number7
DOIs
Publication statusPublished - Jul 2022

Keywords

  • engineered circular RNA
  • miR-29b sponge
  • muscle atrophy

Fingerprint

Dive into the research topics of 'Engineered Circular RNA CircmiR-29b Attenuates Muscle Atrophy by Sponging MiR-29b'. Together they form a unique fingerprint.

Cite this